Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vvi19g0072 | ATGAGGTATCTGCAAGGCACATCAATGGACGGGCCCATTCCTTCTACTATATCCCAGTTGAAAAACTTAATCGAGTTGGTGATGAGAAATTGCTCCATTACAGACTATTCCTTGTATATCAATTGTGGAGGAGAGGAAACAACTTTTAAAGGGAAGACATATGAAAAAGACAACAATGTTGAGGGTGCGTCACAGTTCTTTACTGATGGTATAGACAAATGGGCTTATAGCAGTACAGGGGCTTTCATAGGTAACCAGGGTGGTAGTCACCTAGCCAAAAACACATCTGCTTTGAACTCAGAGGATGCAGAGATGTACCAAACTGCTCGTCTTGCTCCCATCTCACTCAAGTATTATGGGCTTTGCTTGCGAAAGGGCCCTTATAAAGTGCGACTCCAATTTGCTGAAATCATGTTTTTTAGTAACCAGACATTTGGTAGCCTTGGGAGGCGCTTGTTCCACGTTTCAATTCAAGGGAATGTAGTTTTGAAGGATTTTAATATCATGGAAGAAGCTAAAGGTGCTGGTAAGGGCATTTATAGGGATTTTGATGCCTCTGTTGATGGTAGCACTCTGGAGATCCACTTATACTGGACAGGCAAAGGGACTAATTCCATTCCGGATGAAGGTGTATATGGGCCTCTTATATCTGCTATTGCAGTGACACCAAAATTCAATCCCAACCCGGGGCTGTCTGTTGGAGATATCATCGGCATTGTGATACCTTCATGTGTGGTCCTCGTATTGATTTTGGTACTCCTACGAATGAAAGGCTACTTAGGAGGAAAAGACCTTGAAGATAGAGAACTACGTGAGCTAGGGATGCAAACTGGTTATTTTAGTTTACGACAGATCAAAGCTGCTACCAATAACTTTGACTCTGCAAATAAGATTGGTGAAGGTGGATTTGGGCCAGTCTACAAGGGTGTACTGTCAGATGGTTCAGTAATTGCTGTTAAGCAGCTCTCTTCTAAATCAAAGCAAGGGAACCGAGAATTTGTAAATGAAATAGGCATGATATCTGCCTTACAACACCCAAATCTTGTGAAGCTTTATGGCTGTTGTATTGAAGGGAACCAGTTGTTGCTCATATACGAATATTTGGAAAACAATTGTCTTGCACGTGCACTTTTTGGTTCCGAAGAACAGCGGCTAAATTTGGACTGGCCAACTAGGAAGAAGATATGCTTGGGGATAGCAAGGGGATTGGCATATCTTCATGAGGAGTCAAGATTGAAAATTGTTCATAGAGATATAAAGGCAACAAATGTGCTGCTTGATAAGAATCTAAATGCTAAGATATCTGACTTTGGCTTGGCTAAGCTGGATGAAGACGAGAACACCCATATCAGCACACGGATAGCTGGAACGATAGGATACATGGCTCCTGAATATGCAATGAGGGGTTACTTGACCGACAAAGCAGATGTTTACAGCTTTGGAATTGTTGCTTTAGAGATTGTCAGCGGAAAAAGCAACACCAATTACAGGCCAAAGGAAGAGTTTGTTTATCTTCTTGATTGGGCTTATGTCCTGCACGAGCAGGGAAACCTTCTGGAGCTGGTGGATCCAAGTCTTGGATCAAACTATTCAGAGGAGGAGGTGATGAGGATGCTGAACTTGGCCCTCTTATCCACCAACCAGTCTCCCACTCTCAGGCCATCCATGTCCTCTGTGGTGAGTATGCTTGATGGCAAAATTGCAGTCCAAGCACCAACGATCAAGCATGATTCGATGAACCCAGATATGCGATTCAAAGCCTTTGAGAAGCTCTCACTGGACAGCCAGTCTCATGTCTCAGCATTCTCTGTAGACAGTCAGGACCAAGGCAGCATATCAGTTGATGGGCCATGGGTTGATTCCTCAATTTCCCTCCATAGCAGAGAAGAAACAAGGGGATTTCCTTCATCGAGCAAGAGAACGCCCACATCAGCACAAAATAGCTGGAACAAGGCTCAACTTCTGCCAGAGGATGAAGTGCAAACTCTTGAGACAATAGCCACAAGATTGAATAACAGATACTGGAACATCAGCCAAACCTCTTGTGGAGGAGGTTTCAATGTGAATTTCACCTCCGACTATTTTAGCAACGTTACATGTGACTGTACTTTCGAGAACTCCACTGTTTGCCATGTCACAAACATCCAGCTGAAGGGTCTTAATTTAACTGGTATTATGCCTGATGAGTTTGGAAATCTTACTTACCTGCAAGAAATTGATCTCACCCGCAACTATCTCAATGGATCAATCCCTACAAGTCTTGCCCAGATTCCTCTTGTCACTCTGTCTGCTTTGGGAAACCGTCTCTCTGGGTCAATTCCTAAGGAAATTGGTGACATTGCTACACTTGAGGAGCTGGTCTTGGAAGATAATCAGCTAGAAGGATCCCTTCCTGAAAACCTTGGAAATTTGAGCAGTTTGAGTAGACTCCTTCTTACTGCAAACAATTTTACGGGAACAATACCAGAAACGTTTGGCAATCTGAAAAATTTAACTGATGTTCGGTTAGATGGGAATGCATTTTCAGGGAAGATACCAGATTTTATTGGGAATTGGACCCAACTTGACAGGCTAGATATGCAAGGCACATCCATGGACGGTCCCATTCCTTCTACCATATCCCTGTTGACAAACTTGACTCAGTTGAGAATAGCTGATTTGAATGGATCATCTATGGCTTTCCCCAACTTGCAGAATTTGACAAAGATGGAAGAACTGGTACTGAGAAATTGCTCAATTACCGACTCAATCCCAGACTACATTGGAAAAATGGCATCTTTGAAAACATTAGACCTGAGCTTCAACAGATTGAGTGGTCAAGTTTCAGATACATGGAGTTTGTCACAACTGGAATATCTGTTTCTGACTAACAACTCTTTGAGTGGAACACTACCCAGTTGGATATCAGACAGCAACCAGAAATTTGATGTATCTTACAACAACTTTACAGGGCCGTCGTCTCTCACAGTTTGCCAGCAAAGGGCCGTGAACTTAGTTTCCAGTTTTTCATCTTCAGACAGCAACTCAGTATTATGGTGTCTTAAGAAGGGTCTCCCCTGCCCTGGAAATGCCAAACACTATTCCTTGTTTATTAATTGTGGAGGATCTGAGATTAACTACGAGGGAAATGACTATGAAAGGGACTTAGATGGATCGGGTGCATCACACTTCAGTGATTATTCAGAAAAATGGGGTTATAGTAGCACAGGGGTTTTCACAAACAATGACGATGCTGCTTATGTAGCAACAAACACATTTTCTCTGAATATAACGGGTCCAGAGTACTTACAAACAGCTCGCACTTCTCCTATATCGCTCAAGTATTATGGTCTCTGCATGCGAAAGGGCAGCTACAGAGTGCAACTCCACTTTGCTGAAATTATGTTTTCTGATGATGAGACATTTAGCAGCTTGGGGAAGCGCATTTTTGATGTTTCTATCCAAGGGGTTACAGTCTTGAAGGATTTTAACATTGTGGAGGAAGCTAAAGGTGTTGGTAAAGCCATCACTAAGGATTTTGAGACTTCTGTTAATGGTAGCACTCTGGAGATCCATTTATACTGGGCAGGCAAAGGGACTAATGCCATTCCTAGTAGAGGTGTATATGGACCTCTTATATCCGCTATTACAGTGACACCAAACTTTGATGTCAGCACAGGGCTATCTGCTGGAGCTATTGCTGGTATTGTAATTGCTTCAATTGCGGCTGTTGTTTTGATTTTGATAGTCCTCAGACTGACAGGCTACCTAGGAGGGAAAGACCAAGAAGATAAAGAACTTCAAGCACTAAAGCTACAAACTGGTTATTTCAGTTTAAGACAGATCAAAGCTGCTACCAATAACTTTGATCCTGCAAATAAGATAGGTGAAGGTGGATTTGGGCCCGTTTACAAGGGTGTACTCCCAGATGGTTCAGTAATTGCGGTCAAGCAGCTCTCCTCCAAATCAAAACAAGGGAACCGTGAATTTGTCAATGAGATAGGCATGATATCTGCCTTGCAACACCCAAATCTAGTGAAGCTTTATGGCTGGTGTATTGAAGGAAACCAGTTGTTGCTCATATACGAATATTTGGAAAACAATTGTCTTGCACGTGCACTTTTTGGTCGCATTGAACAGCGGCTAAATTTGGACTGGCCAACAAGAAATAAAATATGCTTGGGGATAGCAAGGGGACTGGCATATCTACACGAGGAGTCAAGGTTGAAAATTGTTCACAGAGATATCAAGGCAACCAATGTGCTGCTTGATAAGGATCTAAATGCGAAGATATCTGACTTTGGTTTAGCTAAACTTGATGAAGAAGAGAACACACACATCAGCACACGTATCGCTGGAACAATAGGATACATGGCTCCTGAATATGCGATGAGGGGTTACTTGACAGACAAAGCAGATGTTTACAGCTTTGGAATCGTTGCTCTAGAGATTGTCAGTGGGAAAAGCAACACCAATTACAGGCCCAAGGAGGAGTTTGTCTATCTTCTTGACTGGGCTTATGTCCTACAAGAGCAAGAAAACCTTCTCGAACTCGTGGATCCAAGTCTTGGTTCGAAGTACTCCAAAGAAGAGGCACAAAGGATGCTGAACTTGGCTCTCCTGTGCGCCAACCCGTCTCCCACTCTCAGGCCATCCATGTCTTCTGTAGTGAGTATGCTCGAAGGCAAAACTGCAGTCCAAGTACCATTAATCAAGCGTAGCTCAATGAATTCAATGAATTTGGATATGAGGTTCAAAGCCTTCGAGAAGCTGTCACAGGACAGCCAAACATATGTCTCAGAGCGCTCTCAAGGCAGTCAAATGCAAAGGAGCATGTCAATGGATGGACCATGGTTTGGTTCCTCAGTTTCCTTCCCTGATAAAGACAAGACCCGAGAACATTCTTCATCAAGCAAACAGAAACTTCTCCATGACTAA | 4917 | 0.4295 | MRYLQGTSMDGPIPSTISQLKNLIELVMRNCSITDYSLYINCGGEETTFKGKTYEKDNNVEGASQFFTDGIDKWAYSSTGAFIGNQGGSHLAKNTSALNSEDAEMYQTARLAPISLKYYGLCLRKGPYKVRLQFAEIMFFSNQTFGSLGRRLFHVSIQGNVVLKDFNIMEEAKGAGKGIYRDFDASVDGSTLEIHLYWTGKGTNSIPDEGVYGPLISAIAVTPKFNPNPGLSVGDIIGIVIPSCVVLVLILVLLRMKGYLGGKDLEDRELRELGMQTGYFSLRQIKAATNNFDSANKIGEGGFGPVYKGVLSDGSVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNCLARALFGSEEQRLNLDWPTRKKICLGIARGLAYLHEESRLKIVHRDIKATNVLLDKNLNAKISDFGLAKLDEDENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLHEQGNLLELVDPSLGSNYSEEEVMRMLNLALLSTNQSPTLRPSMSSVVSMLDGKIAVQAPTIKHDSMNPDMRFKAFEKLSLDSQSHVSAFSVDSQDQGSISVDGPWVDSSISLHSREETRGFPSSSKRTPTSAQNSWNKAQLLPEDEVQTLETIATRLNNRYWNISQTSCGGGFNVNFTSDYFSNVTCDCTFENSTVCHVTNIQLKGLNLTGIMPDEFGNLTYLQEIDLTRNYLNGSIPTSLAQIPLVTLSALGNRLSGSIPKEIGDIATLEELVLEDNQLEGSLPENLGNLSSLSRLLLTANNFTGTIPETFGNLKNLTDVRLDGNAFSGKIPDFIGNWTQLDRLDMQGTSMDGPIPSTISLLTNLTQLRIADLNGSSMAFPNLQNLTKMEELVLRNCSITDSIPDYIGKMASLKTLDLSFNRLSGQVSDTWSLSQLEYLFLTNNSLSGTLPSWISDSNQKFDVSYNNFTGPSSLTVCQQRAVNLVSSFSSSDSNSVLWCLKKGLPCPGNAKHYSLFINCGGSEINYEGNDYERDLDGSGASHFSDYSEKWGYSSTGVFTNNDDAAYVATNTFSLNITGPEYLQTARTSPISLKYYGLCMRKGSYRVQLHFAEIMFSDDETFSSLGKRIFDVSIQGVTVLKDFNIVEEAKGVGKAITKDFETSVNGSTLEIHLYWAGKGTNAIPSRGVYGPLISAITVTPNFDVSTGLSAGAIAGIVIASIAAVVLILIVLRLTGYLGGKDQEDKELQALKLQTGYFSLRQIKAATNNFDPANKIGEGGFGPVYKGVLPDGSVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGWCIEGNQLLLIYEYLENNCLARALFGRIEQRLNLDWPTRNKICLGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQENLLELVDPSLGSKYSKEEAQRMLNLALLCANPSPTLRPSMSSVVSMLEGKTAVQVPLIKRSSMNSMNLDMRFKAFEKLSQDSQTYVSERSQGSQMQRSMSMDGPWFGSSVSFPDKDKTREHSSSSKQKLLHD* | 1639 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vvi19g0072 | 1638 | CDD | STKc_IRAK | 298 | 565 | - | - | |
Vvi19g0072 | 1638 | PANTHER | LEUCINE-RICH REPEAT-CONTAINING PROTEIN DDB_G0281931-RELATED | 3 | 595 | - | - | |
Vvi19g0072 | 1638 | Gene3D | Phosphorylase Kinase; domain 1 | 1250 | 1357 | - | - | |
Vvi19g0072 | 1638 | Gene3D | Phosphorylase Kinase; domain 1 | 263 | 367 | - | - | |
Vvi19g0072 | 1638 | FunFam | probable LRR receptor-like serine/threonine-protein kinase At1g53430 | 261 | 367 | - | - | |
Vvi19g0072 | 1638 | MobiDBLite | consensus disorder prediction | 627 | 648 | - | - | |
Vvi19g0072 | 1638 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 414 | 426 | IPR008271 | GO:0004672|GO:0006468 | |
Vvi19g0072 | 1638 | MobiDBLite | consensus disorder prediction | 628 | 648 | - | - | |
Vvi19g0072 | 1638 | SUPERFAMILY | L domain-like | 690 | 939 | - | - | |
Vvi19g0072 | 1638 | ProSiteProfiles | Protein kinase domain profile. | 292 | 574 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vvi19g0072 | 1638 | Gene3D | Ribonuclease Inhibitor | 890 | 998 | IPR032675 | - | |
Vvi19g0072 | 1638 | SUPERFAMILY | Protein kinase-like (PK-like) | 1267 | 1573 | IPR011009 | - | |
Vvi19g0072 | 1638 | MobiDBLite | consensus disorder prediction | 1589 | 1638 | - | - | |
Vvi19g0072 | 1638 | Pfam | Malectin domain | 1028 | 1209 | IPR021720 | - | |
Vvi19g0072 | 1638 | Pfam | Malectin domain | 37 | 219 | IPR021720 | - | |
Vvi19g0072 | 1638 | SMART | serkin_6 | 1282 | 1553 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vvi19g0072 | 1638 | SMART | serkin_6 | 292 | 563 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vvi19g0072 | 1638 | Gene3D | Transferase(Phosphotransferase) domain 1 | 368 | 577 | - | - | |
Vvi19g0072 | 1638 | ProSiteProfiles | Protein kinase domain profile. | 1282 | 1564 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vvi19g0072 | 1638 | CDD | STKc_IRAK | 1288 | 1555 | - | - | |
Vvi19g0072 | 1638 | MobiDBLite | consensus disorder prediction | 1619 | 1638 | - | - | |
Vvi19g0072 | 1638 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase | 368 | 575 | - | - | |
Vvi19g0072 | 1638 | FunFam | Probable LRR receptor-like serine/threonine-protein kinase At1g53420 | 656 | 888 | - | - | |
Vvi19g0072 | 1638 | Pfam | Protein tyrosine and serine/threonine kinase | 295 | 512 | IPR001245 | GO:0004672|GO:0006468 | |
Vvi19g0072 | 1638 | Pfam | Protein tyrosine and serine/threonine kinase | 1286 | 1553 | IPR001245 | GO:0004672|GO:0006468 | |
Vvi19g0072 | 1638 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 1404 | 1416 | IPR008271 | GO:0004672|GO:0006468 | |
Vvi19g0072 | 1638 | SUPERFAMILY | Protein kinase-like (PK-like) | 275 | 579 | IPR011009 | - | |
Vvi19g0072 | 1638 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase | 1358 | 1565 | - | - | |
Vvi19g0072 | 1638 | Gene3D | Ribonuclease Inhibitor | 656 | 889 | IPR032675 | - | |
Vvi19g0072 | 1638 | Gene3D | - | 1024 | 1214 | - | - | |
Vvi19g0072 | 1638 | Gene3D | - | 34 | 224 | - | - | |
Vvi19g0072 | 1638 | FunFam | probable LRR receptor-like serine/threonine-protein kinase At1g53430 | 1251 | 1357 | - | - | |
Vvi19g0072 | 1638 | Pfam | Leucine rich repeat | 902 | 960 | IPR001611 | GO:0005515 | |
Vvi19g0072 | 1638 | Gene3D | Transferase(Phosphotransferase) domain 1 | 1358 | 1570 | - | - | |
Vvi19g0072 | 1638 | FunFam | Putative leucine-rich repeat receptor-like serine/threonine-protein kinase | 35 | 224 | - | - | |
Vvi19g0072 | 1638 | MobiDBLite | consensus disorder prediction | 1589 | 1611 | - | - | |
Vvi19g0072 | 1638 | FunFam | Putative leucine-rich repeat receptor-like serine/threonine-protein kinase | 1026 | 1214 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vvi19g0072 | Vvi-Chr19 | 831667 | 864165 | Dispersed/Proximal |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vvi19g0072 | 37 | 629 | Receptor kinase-like Gene Family | AT1G53440 | 68.605 | 0.0 | 825 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_DLSV | Vvi19g0072 | PK_Tyr_Ser-Thr | 2.9e-48 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vvi19g0072 | - | - | vvi:100260595 | 1902.87 |